Literature DB >> 23138169

Prevention and treatment of cancer-related infections.

Lindsey Robert Baden, William Bensinger, Michael Angarone, Corey Casper, Erik R Dubberke, Alison G Freifeld, Ramiro Garzon, John N Greene, John P Greer, James I Ito, Judith E Karp, Daniel R Kaul, Earl King, Emily Mackler, Kieren A Marr, Jose G Montoya, Ashley Morris-Engemann, Peter G Pappas, Ken Rolston, Brahm Segal, Susan K Seo, Sankar Swaminathan, Maoko Naganuma, Dorothy A Shead.   

Abstract

Patients with cancer are at increased risk for developing infectious complications during the course of their disease and treatment. The following sections of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and Treatment of Cancer-Related Infections provide an overview of the risk factors for infectious complications, recommendations for infectious risk categorization, and strategies for prevention of infections in high-risk patient populations with cancer. Individualized risk evaluation for infections and incorporation of preventative measures are essential components of the overall spectrum of cancer care, and may contribute to optimizing treatment outcomes for patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23138169     DOI: 10.6004/jnccn.2012.0146

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  52 in total

1.  Multi-organ involvement secondary to varicella zoster virus, herpes simplex virus and cytomegalovirus in an immunocompromised patient.

Authors:  Ripal Jariwala; Kristen Zeitler; Nicole D Riddle; Chakrapol Sriaroon
Journal:  BMJ Case Rep       Date:  2019-03-31

2.  Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia.

Authors:  Lisa M Daniels; Urshila Durani; Jason N Barreto; John C O'Horo; Mustaqeem A Siddiqui; John G Park; Pritish K Tosh
Journal:  Support Care Cancer       Date:  2019-02-25       Impact factor: 3.603

Review 3.  Management of patients with hepatitis B who require immunosuppressive therapy.

Authors:  Jessica P Hwang; Anna S-F Lok
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-11-19       Impact factor: 46.802

4.  Ertapenem usage in cancer patients with and without neutropenia: a report on 97 cases from a comprehensive cancer center.

Authors:  L Nesher; F P Tverdek; S N Mahajan; R F Chemaly; Kenneth V I Rolston
Journal:  Infection       Date:  2015-05-01       Impact factor: 3.553

Review 5.  Crisis management in the treatment of childhood acute lymphoblastic leukemia: putting right what can go wrong (emergency complications of disease and treatment).

Authors:  Rachael Hough; Ajay Vora
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

6.  Do inhaled corticosteroids increase the risk of Pneumocystis pneumonia in people with lung cancer?

Authors:  Sameh Msaad; Ilhem Yangui; Najla Bahloul; Narjes Abid; Makram Koubaa; Yosr Hentati; Mounir Ben Jemaa; Samy Kammoun
Journal:  World J Clin Cases       Date:  2015-09-16       Impact factor: 1.337

7.  Outpatient management without initial assessment for febrile patients undergoing adjuvant chemotherapy for breast cancer.

Authors:  Kosei Kimura; Satoru Tanaka; Mitsuhiko Iwamoto; Hiroya Fujioka; Nayuko Sato; Risa Terasawa; Kanako Kawaguchi; Junna Matsuda; Nodoka Umezaki; Kazuhisa Uchiyama
Journal:  Mol Clin Oncol       Date:  2016-08-12

8.  Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: a 12-year single institution study.

Authors:  Susan K Seo; Kun Xiao; Yao-Ting Huang; Ubonvan Jongwutiwes; Dick Chung; Molly Maloy; Sergio Giralt; Juliet N Barker; Ann A Jakubowski; Genovefa A Papanicolaou
Journal:  J Infect       Date:  2014-06-12       Impact factor: 6.072

9.  Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.

Authors:  Gary D Peksa; Kathryn Schultz; Henry C Fung
Journal:  J Oncol Pharm Pract       Date:  2014-06-17       Impact factor: 1.809

10.  The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma.

Authors:  Maria Del Castillo; Fabian A Romero; Esther Argüello; Chrisann Kyi; Michael A Postow; Gil Redelman-Sidi
Journal:  Clin Infect Dis       Date:  2016-08-07       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.